March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Differential Expression Of Genes In Conjunctival Tissue, And Primary Conjunctival Fibroblasts, From Mucous Membrane Pemphigoid Patients
Author Affiliations & Notes
  • Sarah B. Dale
    Ocular Biology & Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
  • Valerie P. Saw
    Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
  • John K. Dart
    Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
  • David J. Abraham
    Centre for Rheumatology Research and Connective Tissue Diseases, The Royal Free Campus, UCL, London, United Kingdom
  • Julie T. Daniels
    Ocular Biology & Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
  • Footnotes
    Commercial Relationships  Sarah B. Dale, None; Valerie P. Saw, None; John K. Dart, None; David J. Abraham, None; Julie T. Daniels, None
  • Footnotes
    Support  Fight for Sight Grant DGMF
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2704. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah B. Dale, Valerie P. Saw, John K. Dart, David J. Abraham, Julie T. Daniels; Differential Expression Of Genes In Conjunctival Tissue, And Primary Conjunctival Fibroblasts, From Mucous Membrane Pemphigoid Patients. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2704.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Conjunctival gene expression profiles of patients with ocular mucous membrane pemphigoid (MMP) with (PemI) or without (PemU) inflammation and controls (C) were compared to identify any differential expression. These gene expression profiles were also compared to those of primary conjunctival fibroblasts explanted from PemI (F-PemI), PemU (F-PemU), and C (F-C) conjunctival tissue which are the focus of our in vitro model of fibroblast activity in MMP.

Methods: : Total RNA from conjunctival tissue of 12 MMP patients and 5 age-matched controls (PemI, n=6; PemU, n=6; C, n=5) and from primary conjunctival fibroblasts from 4 MMP patients and 2 controls (F-PemI, n=2; F-PemU, n=2; F-C, n=2) was isolated with RNeasy Micro Kit. The MMP patients all had biopsy confirmed MMP (PemI, n=12; PemU, n=4). Quality and concentration of the total RNA was analysed using the NanoDrop ND-1000 and a Bioanalyser. Microarray experiments were performed at Cambridge Genomic Services, using the HumanHT-12 v4 BeadChip.

Results: : 65 genes are showing at least a 2 fold increased expression within PemI and PemU tissue in comparison with C tissue. A selection of these genes are involved with inflammatory, wound healing and immune responses, and their increased expression differs between PemI and PemU tissue. These genes are also expressed in the F-PemI, F-PemU and F-C primary fibroblasts.

Conclusions: : MMP conjunctival tissue exhibits a differentially expressed gene profile compared to healthy conjunctiva. Elements of this profile are maintained in-vitro within MMP primary fibroblasts. These findings support the utility of our in-vitro model of fibroblast activity in MMP, through which scarring mechanisms in MMP may be elucidated, and anti-scarring strategies investigated.

Keywords: conjunctiva • wound healing • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×